Bristol Myers Squibb Stock Price Prediction
| BMYMP Stock | USD 845.00 73.55 8.01% |
Oversold Vs Overbought
59
Oversold | Overbought |
Using Bristol-Myers Squibb hype-based prediction, you can estimate the value of Bristol Myers Squibb from the perspective of Bristol-Myers Squibb response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bristol-Myers Squibb to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bristol-Myers because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bristol-Myers Squibb after-hype prediction price | USD 845.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bristol-Myers |
Bristol-Myers Squibb After-Hype Price Prediction Density Analysis
As far as predicting the price of Bristol-Myers Squibb at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bristol-Myers Squibb or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bristol-Myers Squibb, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bristol-Myers Squibb Estimiated After-Hype Price Volatility
In the context of predicting Bristol-Myers Squibb's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bristol-Myers Squibb's historical news coverage. Bristol-Myers Squibb's after-hype downside and upside margins for the prediction period are 842.25 and 847.75, respectively. We have considered Bristol-Myers Squibb's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bristol-Myers Squibb is very steady at this time. Analysis and calculation of next after-hype price of Bristol Myers Squibb is based on 3 months time horizon.
Bristol-Myers Squibb Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bristol-Myers Squibb is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol-Myers Squibb backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bristol-Myers Squibb, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.14 | 2.75 | 0.00 | 0.01 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
845.00 | 845.00 | 0.00 |
|
Bristol-Myers Squibb Hype Timeline
Bristol Myers Squibb is currently traded for 845.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Bristol-Myers is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at 0.14%. %. The volatility of related hype on Bristol-Myers Squibb is about 5612.24%, with the expected price after the next announcement by competition of 845.01. The company last dividend was issued on the 1st of December 2022. Assuming the 90 days horizon the next expected press release will be in 5 to 10 days. Check out Bristol-Myers Squibb Basic Forecasting Models to cross-verify your projections. To learn how to invest in Bristol-Myers Pink Sheet, please use our How to Invest in Bristol-Myers Squibb guide.Bristol-Myers Squibb Related Hype Analysis
Having access to credible news sources related to Bristol-Myers Squibb's direct competition is more important than ever and may enhance your ability to predict Bristol-Myers Squibb's future price movements. Getting to know how Bristol-Myers Squibb's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bristol-Myers Squibb may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NVSEF | Novartis AG | 0.00 | 0 per month | 1.67 | (0.06) | 5.31 | (3.71) | 11.25 | |
| BAYZF | Bayer AG | 0.00 | 0 per month | 0.00 | (0.12) | 4.69 | (2.74) | 18.64 | |
| ALPMF | Astellas Pharma | 0.00 | 0 per month | 2.43 | (0.03) | 4.40 | (6.77) | 19.92 | |
| RHHVF | Roche Holding AG | 0.00 | 0 per month | 0.00 | (0.19) | 1.79 | (2.47) | 5.44 | |
| ALPMY | Astellas Pharma | 0.00 | 0 per month | 0.00 | (0.11) | 2.57 | (3.48) | 10.71 | |
| DSKYF | Daiichi Sankyo | 0.00 | 0 per month | 0.00 | (0.03) | 9.48 | (8.48) | 24.99 | |
| AZNCF | AstraZeneca PLC | 0.00 | 0 per month | 0.00 | (0.23) | 2.94 | (4.54) | 12.29 | |
| CHGCY | Chugai Pharmaceutical Co | 0.00 | 0 per month | 1.88 | 0.03 | 4.14 | (3.00) | 12.48 | |
| RHHBY | Roche Holding Ltd | 0.00 | 0 per month | 0.00 | (0.18) | 1.20 | (2.76) | 7.58 | |
| GSK | GlaxoSmithKline PLC ADR | 0.49 | 8 per month | 0.00 | (0.19) | 2.12 | (2.56) | 8.88 |
Bristol-Myers Squibb Additional Predictive Modules
Most predictive techniques to examine Bristol-Myers price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bristol-Myers using various technical indicators. When you analyze Bristol-Myers charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bristol-Myers Squibb Predictive Indicators
The successful prediction of Bristol-Myers Squibb stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bristol Myers Squibb, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bristol-Myers Squibb based on analysis of Bristol-Myers Squibb hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bristol-Myers Squibb's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bristol-Myers Squibb's related companies.
Story Coverage note for Bristol-Myers Squibb
The number of cover stories for Bristol-Myers Squibb depends on current market conditions and Bristol-Myers Squibb's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bristol-Myers Squibb is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bristol-Myers Squibb's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Bristol-Myers Squibb Short Properties
Bristol-Myers Squibb's future price predictability will typically decrease when Bristol-Myers Squibb's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bristol Myers Squibb often depends not only on the future outlook of the potential Bristol-Myers Squibb's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bristol-Myers Squibb's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 B | |
| Cash And Short Term Investments | 17.2 B |
Additional Tools for Bristol-Myers Pink Sheet Analysis
When running Bristol-Myers Squibb's price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.